炎症性肠病与原发性硬化性胆管炎:一种疾病还是两种疾病?
本文综述原发性硬化性胆管炎(PSC)与炎症性肠病(IBD)的流行病学、特定表型、并发症及潜在病理生理机制,讨论PSC是IBD的肠外表现还是两者为共享易感性的两种独立疾病,并探讨两者共同管理的启示。
要点
- PSC与IBD关联密切,多数PSC患者被诊断为广泛性结肠炎。
- PSC是仅作为IBD的肠外表现,还是与IBD为两种独立疾病,尚存争议。
- 综述总结PSC-IBD现有数据,讨论两者是一种还是两种疾病。
核心结论
- 本综述总结PSC-IBD的现有数据,讨论PSC与IBD是一种还是两种疾病。
研究设计与样本
- 综述,描述PSC中IBD的流行病学、特定表型、并发症及连接两种疾病的潜在病理生理机制。
主要发现
- PSC最显著特征之一是与IBD的关联,多数PSC患者被诊断为广泛性结肠炎。
- PSC是仅作为IBD的肠外表现,还是PSC与IBD为两种独立疾病但共享易感性导致双重表型,存在争议。
临床怎么用
- 综述讨论两种疾病共同管理的启示。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Primary sclerosing cholangitis (PSC) was declared one of the biggest unmet needs in hepatology during International Liver Congress 2016 in Berlin. Since then, not much has changed unfortunately, largely due to the still elusive pathophysiology of the disease. One of the most striking features of PSC is its association with inflammatory bowel disease (IBD), with the majority of patients with PSC being diagnosed with extensive colitis. This review describes the epidemiology of IBD in PSC, its specific phenotype, complications and potential pathophysiological mechanisms connecting the two diseases. Whether PSC is merely an extra-intestinal manifestation of IBD or if PSC and IBD are two distinct diseases that happen to share a common susceptibility that leads to a dual phenotype is debated. Implications for the management of the two diseases together are also discussed. Overall, this review summarises the available data in PSC-IBD and discusses whether PSC and IBD are one or two disease(s).
引用
- van Munster KN, Bergquist A, Ponsioen CY, et al. Inflammatory bowel disease and primary sclerosing cholangitis: One disease or two? J Hepatol. 2023. PMID: 37940453. doi:10.1016/j.jhep.2023.09.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。